Home -> Law Blog Directory -> Personal Injury Law Blogs -> Bodily Injury Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Bodily Injury BlogJapanese Company to Recall Injection Drugs
By Edward Bills
Mitsubishi Tanabe Pharma Corp. has announced a recall of 2 million shots of injection drugs after it was discovered they were not tested for quality control before leaving a Japanese factory. The drugs being recalled are Liple, Limethason and Pazucross, used to treat various illnesses. The company said it has received no reports of illnesses associated with the medications.
Full post as published by Bodily Injury Blog on January 26, 2011 (boomark / email).
Bausch Lomb Renu Moistureloc Linked to Eye Infection Fusarium Keratiti
Contact Lens Solution Product Recall
Bausch Lomb Renu Moistureloc Recall
Contact Lens Solution Product Recall
California Limited Liability Company Formation
Relevant information for starting a limited liability company in California
Stock Splits and Reverse Stock Splits
How splits can affect stock value
Pet Food Recall and Deaths
Dogs and Cats Sickened by Tainted Menu Food Products
Mattel and Fisher-Price Toy Recall
Magnets and Lead Paint manufactured in China Create Poisoning and Health Hazard
Dobutamine Hydrochloride Injection
Labeling Errors Prompts Recall of 250 mg/20 ml Injections
FDA Issues Warning about Promethazine Hydrochloride Injection
Promethazine Hydrochloride Injection FDA issues warning
Piperacillin/Tazobactam for Injection Recalled
Health Canada Warns of Health Risks
GlaxoSmithKline Pays $750 Million Over Defective Drugs
GlaxoSmithKline Pays $750 Million Over Defective Drugs
Fake Drugs
Life Threatening Incidents
Imported Diets
Pills Contain Illegal Drugs

Where Texas Obtains Its Lethal Injection Drugs
Texas & Arkansas Stocked with Execution Drugs
Japanese drug company will pay $4 million to settle FCA charges
The FDA and Lethal Injection Drugs
Congress Investigating Johnson & Jonson's "Phantom Recall"
FDA Issues a Recall on Class of Bone Drugs








